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Abstract
Background: Inborn errors of metabolism (IEM) are a group of rare, heterogeneous and complex genetic
conditions. Clinically, IEM often affect the central nervous system and other organs. Some carry the risk of
progression and / or potentially life-threatening crises. Many patients have to adhere to lifelong dietary or drug
treatment.
The complexity of IEM makes it difficult for patients and caregivers to understand their pathophysiology, inheritance
and therapy rationale. Especially patients reaching adolescence may have only limited knowledge of their condition
since medical care has often entirely been handled by their parents. Knowledge about disease and treatment,
however, constitute pillars of self-responsible disease management. Not many standardized patient education
materials on IEM are available and their comprehensibility has not been systematically investigated.
Methods: We developed and tested patient education materials for school-aged children and adolescents with
IEM. Informative texts and illustrations in paper form and as videos were developed by an international network of
metabolic care professionals together with a graphic artist and experts for easy-to-read language. The materials
were presented in standardized single or group training sessions to 111 individuals; first, to 74 healthy children and
adolescents (recruited via public schools) and consecutively to 37 paediatric patients with IEM (phenylketonuria,
galactosemia, urea cycle defects, lysosomal storage disorders) from six metabolic centres. Knowledge-gain was
assessed by pre- and post-testing.
Results: Knowledge-gain was significant in healthy children and adolescents as well as in patients (p < .001, r =. -77
/. -70). Effect sizes were large in both groups (r = -.77 / -.70). This result was independent from family language and
teacher-rated concentration or cognitive capacity in healthy children.
Conclusion: The newly developed patient education materials are a powerful tool to improve disease- and
treatment-related knowledge. They facilitate communication between the medical team and children and
adolescents with IEM and their caregivers.
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Background
Inborn errors of metabolism (IEM) are a group of rare,
heterogeneous genetic conditions typically affecting en-
zyme functioning. Clinically, IEM often affect the central
nervous system but also other organs. Some IEM carry
the risk of “silent” progression while others cause phases
of acute deterioration or even potentially life-threatening
metabolic crises. Most patients carry a high burden of
treatment as they require lifelong dietary and / or drug
treatment (e.g. ammonia scavengers, substrate inhibitors,
enzyme replacement). Adherence to lifelong dietary or
medical treatment is demanding and requires joint ef-
forts of patients and families, healthcare providers, and
institutions such as kindergarten or school.
Recently, questionnaires specifically assessing health-
related quality of life (HrQoL) of patients with phenylke-
tonuria [1] and intoxication type disorders [2] have been
developed. Interviews and focus groups with patients
and parents are integral parts of the construction
process of HrQoL instruments and allow insight into pa-
tients’ and parents’ perspectives. In focus groups and
interviews conducted by our research group [3], patients
and parents communicated that the complexity and
abstractness of IEM and their treatments made it almost
impossible for them to understand the pathophysiology
or treatment rationale - let alone explain this to relatives,
friends or teachers. Consequently, they reported feelings
of frustration, isolation and helplessness in social
situations.
Comprehension of disease, treatment mechanisms and
outcome determinants is an important pillar of success-
ful, self-responsible disease management [4]. Education
materials for children and adolescents with IEM are
sparse and their quality and comprehensibility have
never been investigated.
Processing fluency - defined as the subjective ease with
which an individual is able to process new external in-
formation - constitutes an important determinant of pa-
tient motivation, self-management and adherence [5, 6].
These factors are essential for optimal outcome and tar-
gets of patient education interventions [5, 7]. Standard-
ized materials for continuous comprehensive, attractive,
industry-independent education about the disease and
its treatment are an unmet medical need for paediatric
patients with IEM [8, 9]. It is well known that from age
ten years, dietary adherence in phenylketonuria (PKU)
and acute intoxication-type disorders (e.g. urea cycle
disorders, maple syrup urine disease) declines [10]. This
effect may, at least in part, be attributed to both the
cumbersome transition of health responsibility from par-
ents to patients during adolescence and limited know-
ledge about disease and treatment [11, 12].
This project aimed to develop and test specifically de-
signed, standardized pictorial representations and videos
combined with easy-to-understand texts for structured
and comprehensible medical information on IEM for
school-aged patients and their caregivers. We hypothe-
sised that children and adolescents would be able to in-




Materials were developed in cooperation with a graphic
artist (BR) and specialists for easy to read language (Büro
für Leichte Sprache, Lebenshilfe Bremen, Germany). Six
metabolic physicians, two psychologists and one patient
representative were involved in the development process.
They defined the contents necessary to understand the
basics of IEM and were involved in several feedback
loops to evaluate and refine the paper materials and
videos.
Materials
Initially, a total of 23 modules were developed to explain
different types of IEM, their inheritance and treatment.
Each module consists of 1–2 pages of pictorial presenta-
tions with short easy-to-read text elements. The testing
phase in healthy children and adolescents showed that
the material explaining that the body is built of cells,
which contain genetic information, were too complex.
Hence, the content was reformatted and presented in
two steps, leading to a final set of 24 modules for the
second testing phase in patients. Contents of the mod-
ules are listed in Table 1. Figure 1 shows some examples
(for more refer to [13]). Materials are available in
English, Dutch, and German.
Modules were constructed as to be freely combined by
the metabolic team to explain different inheritance
patterns, IEM of different types (e.g. storage, intoxica-
tion), as well as a variety of treatment options (e.g. scav-
engers, enzyme replacement).
Demographic data, abilities to concentrate and cognitive
capacities
For all children and adolescents willing to participate,
their parents completed a demographic questionnaire on
basic information such as child age and family language.
In the school setting we asked teachers to rate concen-
tration and cognitive capacities. Ability to concentrate
was rated on a four-point Likert-scale. Cognitive capaci-
ties were assessed by using three items with a six-point
Likert-scale indicating fluid intelligence of the THINK
1–4 (Baudson, Wollschläger & Preckel, 2016; Lehrperso-
nen-Einschätzungsskala zu den kognitiven Fähigkeiten;
Test zur Erfassung der Intelligenz im Grundschulalter).
This scale was chosen for its shortness and good internal
consistency of Cronbachs α = .95. Information about
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disease and school setting of the patients was part of the
parent questionnaire.
Comprehensiveness testing
To evaluate the materials, they were assembled for each
testing session to sets of pictures explaining normal
body functions, pattern of inheritance, enzyme function
and dysfunction as well as treatment principles (for ex-
ample normal enzyme functioning, autosomal recessive
inheritance, intoxication of cells, dietary treatment and
metabolite removal by drugs as a set for intoxication-
type disorders). Disease-related knowledge was assessed
before and after the teaching session using 5 to 8 specif-
ically developed multiple choice items (number depend-
ing on content and age) and one open question. Test
items of the knowledge test were developed by a meta-
bolic physician, a psychologist, a psychology master
student and a teacher. Piloting of the comprehensiveness
test was performed in n = 41 children of 4 school classes,
leading to a refinement of the test items and adjustment
of complexity to avoid ceiling effects. Results of this pilot
group are not included in the final analysis. After adap-
tation of the knowledge test, comprehensiveness testing
was performed in healthy children and adolescents and
later in patients. In both groups, materials were pre-
sented in a standardized teaching session given by
trained persons with psychological and / or metabolic
background.
Testing in healthy children and adolescents
Children and adolescents from 1st to 8th school grade
(age 7 to 15 years) from 9 classes in 3 public schools in
the Zurich area (Switzerland) were invited to participate.
Teachers distributed information material and consent
Table 1 Education modules explaining IEM and their treatment




The body The body is built of cells x







The healthy body Building blocks for the body from foods and other sources x x
Enzymes at work in a healthy cell x x
Enzyme defects …in intoxication-type diseases x x
…in storage diseases x x
…in diseases where important substances cannot be produced x x
Treatment Medicine …for intoxication-type diseases x x
…for storage diseases x x
…for diseases where important substances cannot be
produced
x x
Diet …for intoxication-type diseases x x
…for storage diseases x
…for diseases where important substances cannot be
produced
x x
Enzyme helper …for intoxication-type diseases x x
…for storage diseases x x





…for intoxication-type diseases x x
…for storage diseases x x
…for diseases where important substances cannot be
produced
x
Emergency situations Be careful! Recognize dangerous situations (vomiting, fever etc.) x x
aVideo sequences were produced based on the print versions, which were tested in healthy children and adolescents as well as patients. All materials are
available at [13]
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Fig. 1 Example pictures (from top to bottom): (1) Enzymes at work in a healthy cell; (2) Medicine for intoxication-type disease; (3) Be careful!
Recognise dangerous situations
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forms to all children attending their class for discussion
with their parents. Inclusion criteria were informed con-
sent by parents and child, sufficient command of
German and absence of IEM in the family. Hence, this
group is referred to as the healthy group / healthy chil-
dren and adolescents. Two members of the study group
with psychological background performed the testing
(30-45 min per group). Modules were assembled accord-
ing to different case vignettes which were presented to
the groups. Consequently, all modules could be tested.
Modules explaining inheritance were introduced only
from the 5th grade upwards (> 11 years) due to their
complexity and abstractness. Before and directly after
the teaching session, the pre- and a post-knowledge-
testing were performed.
Testing in patients
Convenience samples of patients with IEM from the
metabolic clinics in Amsterdam (NL), Basel (CH),
Bregenz (A), Freiburg (GE), Innsbruck (A) and Zurich
(CH) were invited to participate. Patients were invited
on the occasion of a scheduled visit at the outpatient
clinic (all sites) and additionally during a patient group
meeting (Amsterdam only). Testing was performed in
individual patients or as a group testing with a max-
imum group size of 8 patients. Pre- and post-knowledge
was tested before and directly after a teaching session
with the materials. Duration of the procedure varied
between 25 to 50min. Inclusion criteria were sufficient
command of the German (study sites in Austria,
Germany, and Switzerland) or Dutch (study site in the
Netherlands) language and the ability to participate in
the test situation.
Statistical analyses
Data from the healthy group and the patient group were
analysed independently, since materials were revised
after the school-testing. Percent of correct answers were
compared between pre- and post-testing to analyse
knowledge gain in each of the two samples by Wilcoxon
signed-rank tests. Answers to the open question counted
double due to higher task complexity. Correlation coeffi-
cient r was calculated as an effect size measure for com-
parison of medians to define the magnitude of the
difference between pre- and post-test results (.10 small
effect, .25 medium effect, .40 large effect) [14, 15]. A sig-
nificance level of p < 0.05 was defined to indicate statis-
tical significance. Participants with more than ≥50%
missing answers in one test were excluded from this
analysis.
Spearman’s rank correlation was used to evaluate the
relationship of knowledge gain and pre-test knowledge
with potential influencing variables such as age, family
language (same as language of the materials vs. other
language), concentration and cognitive abilities
(teacher’s rating; only available for the healthy group),
diagnosis of galactosemia (subgroup of patient group),
school type (regular school without additional assist-
ance vs. schooling with assistance; patient group only)
and testing site (country). Galactosemia diagnosis was
chosen as variable in the patient group due to the
well-established high frequency of impaired cognitive
abilities associated with it [16].
All statistical analyses were performed with the statis-
tical software package SPSS, versions 24.0 (IBM Corp.
IBM SPSS Statistics for Windows).
Subjective assessment of materials
Subjective assessment of materials (“how much do you
like the materials?”) was asked on a three point smiley-
scale at the end of the post-test questionnaire. Partici-
pants were encouraged to contribute further comments
on the materials by an open question.
Results
Sample characteristics
One hundred and eleven children and adolescents were
included in testing; 74 healthy children and adolescents
(37 females; age range = 7.23–15.16; mean age = 11.56 ±
2.17) and 37 patients (19 females; age range = 6.96–
19.18; mean age = 11.08 ± 3.17) with IEM (19 with
phenylketonuria, 8 with galactosemia, 3 with propionic
aciduria; 2 with hepatic glycogen storage diseases, 2 with
Pompe disease, 1 each with mucopolysaccharidosis Type
IVa, ornithin transcarbamylase deficiency and LCHAD).
School setting (indicator for cognitive capacities) was
regular school without additional assistance in 21 pa-
tients (57%) and schooling with assistance in 16 (43%)
patients. One patient was excluded from the analyses
due to ≥50% of missing answers in the post-test, but in-
cluded for the subjective assessment of the materials.
Testing of disease-related knowledge
Results of knowledge gain are depicted in Fig. 2. Healthy
children and adolescents showed a significantly higher
percentage of correct answers in the post-test (Mdn =
87.50) than in the pre-test (Mdn = 37.50; z = − 6.60,
p = .000). This difference represents a large effect of r =
− 0.77. Patients also had a higher percentage of correct
answers in the post-test (Mdn = 66.67) compared to the
pre-test (Mdn = 37.50; z = − 4.17, p = .000), which repre-
sents a large effect of r = −.70.
Correlations of knowledge gain with different variables
are reported in detail in Table 2. In the healthy group,
knowledge gain was not significantly related to age,
family language, ability to concentrate or cognitive cap-
acities. In patients, no significant relation was found be-
tween knowledge gain and family language, school type,
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and galactosemia diagnosis. A significant negative correl-
ation was found between knowledge gain and age and
knowledge gain and pre-test knowledge, while pre-test
knowledge and age showed a significant positive
correlation.
Subjective assessment of materials
On a 3-point smiley scale, the majority of the healthy
group (85%) and patients (84%) “liked” the materials, or
rated them as “okay” (healthy group: 3%; patients 14%).
None of the healthy children and adolescents and only
one patient disliked the materials (3%). Nine healthy
children and adolescents (12%) did not answer this
question.
Discussion
Use of unexplained medical jargon with families and pa-
tients is still common in the paediatric field [17] al-
though it has been shown that information, which can
be processed fluently, is considered more trustworthy,
honest and safe and that the recipient is more inclined
and likely to fulfil inferred tasks [5]. Processing fluency
depends mainly on perceptive fluency, determined by
visual display and linguistic fluency, which depends on
wording and grammatical complexity. Our materials
were designed to break down complicated concepts by
pictorial representations and easy-to-read language texts
to achieve good processing fluency for this complex in-
formation [5].
A main strength of our newly developed modular edu-
cational materials is that they have been thoroughly
tested not only in patients from different countries, but
also in naïve healthy children and adolescents. The ma-
terials can be used to educate IEM patients from school
age and parents with any educational background and
family language on different types of IEM (e.g. storage or
intoxication type). They follow a modular system and
thus allow for flexible combinations adaptable to individ-
ual cases, age groups and intellectual capacities, in a
step-by-step approach.
Fig. 2 Knowledge gain in healthy children and adolescents and patients
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Standardized teaching with our newly developed pic-
torial materials had a positive influence on disease-
related knowledge in healthy children and in patients in-
dicating good retrieval fluency of the materials. Know-
ledge gain was not related to age, family language and
teacher’s ratings of concentration abilities and cognitive
capacities in the healthy group. Similarly, family lan-
guage and indicators for cognitive capacities (galacto-
semia, school type) had no influence on knowledge gain
in the patient group. However, knowledge gain was
negatively related to age and pre-test-knowledge in pa-
tients. These results argue against our hypothesis that
adolescents have little disease knowledge.
Experience during the testing sessions in healthy chil-
dren showed that the rather abstract information e.g.
about the body consisting of cells and genetics (DNA,
genes, inheritance) were difficult to convey to younger
children but worked well for adolescents. The contents
how enzymes work and what happens when an enzyme
is not working properly as well as treatment principles
(e.g. diet, enzyme replacement) and information on how
to recognise and act on emergencies were easier to
grasp. Thus, materials about enzyme function, treatment
options and how to act in emergency situations can be
introduced in children from about 7 years of age while
the more abstract topics (e.g. inheritance patterns) can
be discussed in adolescence and / or with parents.
Although we controlled for potential effects of cogni-
tive abilities on the understanding of the materials by
different variables, a limitation of our study is that only
information with regard to the attendance of special
education was collected for the included patients. There-
fore, we were not able to assess the effect of (severe)
cognitive deficits on the test results. The short video se-
quences that were developed based on the cartoons may
be helpful for teaching both younger patients and pa-
tients with limited cognitive abilities, but this was not
specifically tested. Furthermore, our teaching settings
with groups of patients may not be representative for
the usual clinical setting. We hypothesize, however, that
the results should be replicable or may even be better in
a one-to-one setting, which allows to fully focus on the
needs of an individual / a family.
It is known that in patients with chronic diseases ef-
fective health education does not only improve know-
ledge, but also supports adherence to treatment and
successful self-management, by influencing the patients’
attitude and daily practice [17, 18]. All these factors are
essential for optimal outcome in patients with IEM [5,
7]. In this study, so far, we only tested short-term know-
ledge gain. The effect of our materials on adherence,
daily practice and biochemical outcome markers will be
investigated in a next step. To allow wider use of the
materials they will be accessible for professionals, pa-
tients and their families on an attractive patient-oriented
homepage, which is another focus of this ongoing
project.
Medical jargon and incomprehensive disease informa-
tion constitute a barrier to informed and shared
decision-making [17]. Over 80% of the study participants
indicated that they liked the materials and appreciated
them as an indicator of a respectful approach of care.
Table 2 Bivariate correlations of knowledge gain and pre-test knowledge with potential influencing variables
Healthy children and adolescents
1 2 3 4 5 6
1. Knowledge gain – – – – – –
2. Knowledge pre-test − 0.77** – – – – –
3. Age −0.16 0.46** – – – –
4. Family language − 0.19 0.11 0.18 – – –
5. Cognitive capacities 0.10 0.06 −0.05 −0.19 – –
6. Ability to concentrate 0.15 0.00 −0.01 −0.09 0.71** –
Patients
1 2 3 4 5 6 7
1. Knowledge gain – – – – – – –
2. Knowledge pre-test −0.48** – – – – – –
3. Age −0.53** 0.53** – – – – –
4. Family language 0.04 −0.30 −0.12 – – – –
5. Galactosemia 0.18 0.12 − 0.32 0.19 – – –
6. School type −0.13 − 0.14 0.20 − 0.03 −0.27 – –
7. Testing site − 0.07 0.10 0.02 0.09 0.32 0.04 –
**Correlation is significant on the 0.01 level (2-tailed)
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Facilitated communication between patient and meta-
bolic care team may not only enhance patients’ safety,
outcome, attitude towards the care team and quality of
life but does significantly reduce the workload of meta-
bolic professionals due to increased independence of pa-
tients and families [5]. Involvement of parents in
teaching sessions and provision of the materials enables
parents to explain the contents repeatedly to their child
at home and to involve siblings, other family members
or external caregivers to gain social support.
Conclusions
The newly developed materials are a powerful tool to
enhance disease-related knowledge and processing flu-
ency in children and adolescents with IEM from school
age, preparing the ground for participative, safe and easy
communication between patients and the metabolic
team.
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